Melatonin and oral midazolam in sedation for electroencephalography of childre

Not Applicable

• Conditions: Epilepsy.; Episodic and paroxysmal disorders; G40- G47

• Registration Number: IRCT201107182639N5
• Lead Sponsor: Deputy of research -Shahid Sadoughi University of Medical Sciences , Yazd, Iran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

age 1-18 years old; children who are referred to EEG center but don’t obey, , class 1 or 2 of ASA

Exclusion criteria: Presence of gastritis or any other serious systemic diseases, use of sedative in two days ago ; occurrence of severe systemic reaction wth drugs

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sedation induction with achieving of a level of four on the Ramsay scale. Timepoint: every 15 minutes. Method of measurement: clinical.;Success in recording of EEG. Timepoint: one hour after drug use. Method of measurement: clinical.

Secondary Outcome Measures

Name	Time	Method
Serious adverse events (hypotension, hypoxia and cyanosis, severe vomiting, irritability, apnea, laryngospasm, and bradycardia). Timepoint: every 10 minutes. Method of measurement: clinical.;Side effects. Timepoint: every 15 minutes. Method of measurement: clinical.;Time to induction of sedation. Timepoint: every 15 minutes. Method of measurement: clinical.;Caregiver’s satisfaction scale. Timepoint: after 2 hours of drug use. Method of measurement: asking from caregiver.;Total stay time in EEG unit. Timepoint: every 30 minutes. Method of measurement: asking from parents.